Cipla Ltd. — Regulatory Filings 2021

Mar 23, 2021

23[rd] March, 2021

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

Sub: Intimation of re-appointment of Managing Director

In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and Remuneration Committee and subject to approval of the shareholders, and any required regulatory approvals and applicable conditions thereof, the Board of Directors, at its meeting held on 23[rd] March, 2021, has considered and approved the re-appointment of Mr. Umang Vohra (DIN: 02296740), Managing Director, designated as ‘Managing Director and Global Chief Executive Officer’ of the Company, for a further period of five (5) years w.e.f. 1[st] April, 2021 to 31[st] March, 2026 (both days inclusive).

The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9[th] September, 2015 along with the brief profile is given in Annexure A to this letter.

Thanking you,

Yours faithfully, For Cipla Limited

RAJENDR Digitally signed by RAJENDRA CHOPRA DN: c=IN, o=Personal, 2.5.4.20=4987ad48c3965cfde78c8ea69e6 f40ac91535876f12ba1fa5ba45cc5cc8db6 A cb, postalCode=122001, st=HARYANA, serialNumber=0be85c0408d0e3afd6636 69f5314248a72fdcdf34d01d48d472d7cf9 262696f6, cn=RAJENDRA CHOPRA Date: 2021.03.23 14:32:41 +05'30' CHOPRA Rajendra Chopra Company Secretary

Prepared by: Nishtha Agrawal

Annexure A

	Name of the Director	UmangVohra
	DIN	02296740
	Reason for change viz. appointment,~~resignation,~~ ~~removal,~~ ~~death~~ ~~or~~ ~~otherwise~~	Re-appointment of Mr. Umang Vohra (DIN: 02296740), Managing Director, designated as Managing Director and Global Chief Executive Officer of the Company pursuant to end of his current term for a further period of five (5) years w.e.f. 1stApril, 2021 to 31stMarch, 2026(both days inclusive)
	Date of appointment / ~~cessation~~(as applicable) & term of appointment	Period of five (5) years commencing from 1stApril, 2021 to 31st March, 2026. He would be liable to retire byrotation.
	Brief profile	Mr Umang Vohra joined Cipla Limited in 2015 and has been the MD & GCEO of the Company since 1stSeptember, 2016. After gaining degrees in engineering, marketing and finance, Mr Vohra worked with Eicher Motors, PepsiCo and Dr Reddy’s Laboratories. Through his previous roles in India and the US, he has built a distinguished career spanning almost two decades with deep understanding and experience of various aspects of the global pharmaceutical business. As Cipla’s MD & GCEO, Mr Vohra’s priorities have been Cipla’s strategic growth, defining and executing Cipla’s roadmap to maintain momentum in home markets whilst strengthening its presence in other regions, consolidating its core focus areas, augmenting capability, and building the right organisation. Recognised as an action-oriented industry leader, Mr Vohra is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to makinga difference to the lives ofpatients.
	Disclosure of relationships between directors (in case of **appointment of a director). **	Mr. Umang Vohra is not related inter-se to any other Director of the Company.
	Information as required pursuant to BSE Circular with ref. no. LIST/ COMP/ 14/ 2018-19 and the National Stock Exchange of India Ltd with ref. no. NSE/ CML/ 2018/ 24, dated 20th June, 2018	Mr. Umang Vohra is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.